Stay updated on SBRT-Immunotherapy in Early Lung Cancer: Clinical Trial
Sign up to get notified when there's something new on the SBRT-Immunotherapy in Early Lung Cancer: Clinical Trial page.

Latest updates to the SBRT-Immunotherapy in Early Lung Cancer: Clinical Trial page
- Check2 days agoChange DetectedThe study record was updated to version v3.6.5, indicating a new revision of the page. This typically reflects minor editorial or metadata tweaks rather than substantive changes to the trial details.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe page revision was updated from v3.6.3 to v3.6.4, signaling a newer version of the page. This metadata change does not alter the study details or user-facing information.SummaryDifference0.1%

- Check24 days agoChange DetectedResults have been posted for the STILE study, adding comprehensive outcome data (pneumonitis, toxicity, dosing, relapse, overall and disease-free survival, HRQoL) and links to the study protocol and statistical analysis plan. Publications related to the study, including a paper by Mirsadraee et al., are now listed.SummaryDifference5%

- Check38 days agoChange DetectedPage revision updated from v3.6.2 to v3.6.3. This change does not alter the study content or details.SummaryDifference0.1%

- Check46 days agoChange DetectedThe page shows a newer revision build (v3.6.2) replacing the previous v3.6.0, reflecting a minor update to the page's backend or rendering without altering study information.SummaryDifference0.1%

- Check60 days agoChange DetectedRecruitment status changed to 'No longer looking for participants,' indicating no further enrollment. New help/navigation sections were added (How to Read a Study Record, Common Questions, How to Join a Study), and there were minor formatting changes to the Intervention/Treatment heading along with a revision tag update to v3.6.0.SummaryDifference0.4%

Stay in the know with updates to SBRT-Immunotherapy in Early Lung Cancer: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SBRT-Immunotherapy in Early Lung Cancer: Clinical Trial page.